NEURO-ONCOLOGY In search of molecular markers of glioma in elderly patients

被引：9
|
作者：
Hegi, Monika E. [1 ]
Stupp, Roger [2 ,3 ]
机构：
[1] Univ Lausanne Hosp, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland
[2] Univ Zurich Hosp, Dept Oncoloy, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Ctr Canc, CH-8091 Zurich, Switzerland
来源：
NATURE REVIEWS NEUROLOGY | 2013年 / 9卷 / 08期
关键词：
TEMOZOLOMIDE; MUTATIONS; GLIOBLASTOMA; RADIOTHERAPY; TUMORS; CELLS;
D O I：
10.1038/nrneurol.2013.127
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Elderly patients represent a growing proportion of individuals with malignant glioma, but are often excluded from trials owing to their poor prognosis. In a new study, researchers have investigated molecular markers of glioma specifically in elderly patients-are these markers of clinical use?
引用
收藏
页码：424 / 425
页数：2
相关论文
共 50 条
  • [31] Neuro-oncology, a decade of temozolomide and beyond
    Stupp, Roger
    Hegi, Monika
    Weller, Michael
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (11) : 1675 - 1677
  • [32] Temozolomide: a milestone in neuro-oncology and beyond?
    Mutter, Nicole
    Stupp, Roger
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) : 1187 - 1204
  • [33] Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology
    Ranjan, Surabhi
    Skorupan, Nebojsa
    Ye, Xiaobu
    Sivakumar, Ananyaa
    Yankulina, Olga
    Kamson, David Olayinka
    Grossman, Stuart A.
    Dzaye, Omar
    Holdhoff, Matthias
    NEURO-ONCOLOGY PRACTICE, 2020, 7 (01) : 52 - 58
  • [34] Neuro-oncology practices in Australia: A Cooperative Group for Neuro-Oncology patterns of care study
    Chen, James Y.
    Hovey, Elizabeth
    Rosenthal, Mark
    Livingstone, Ann
    Simes, John
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (02) : 162 - 167
  • [35] The inhibitor of integrins Cilengitide: a new active drug in neuro-oncology
    Leblond, Pierre
    Meignan, Samuel
    Le Tinier, Florence
    Bethe, Ullrich
    Lansiaux, Amelie
    BULLETIN DU CANCER, 2011, 98 (09) : 1083 - 1090
  • [36] A hitchhiker's guide to cerebrospinal fluid biomarkers for neuro-oncology
    Riviere-Cazaux, Cecile
    Keough, Michael B.
    Zuccato, Jeffrey A.
    Kumar, Rahul
    Schulz, Sebastian
    Warrington, Arthur E.
    Ruff, Michael W.
    Ellingson, Benjamin M.
    Sanai, Nader
    Campian, Jian L.
    Kizilbash, Sani H.
    Parney, Ian F.
    Zadeh, Gelareh
    Khasraw, Mustafa
    Kessler, Tobias
    Sener, Ugur
    Cahill, Daniel P.
    Mansouri, Alireza
    Burns, Terry C.
    NEURO-ONCOLOGY, 2025,
  • [37] Neuro-Oncology Practice Clinical Debate: long-term antiepileptic drug prophylaxis in patients with glioma
    Stocksdale, Brian
    Nagpal, Seema
    Hixson, John D.
    Johnson, Derek R.
    Rai, Prashant
    Shivaprasad, Akhil
    Tremont-Lukats, Ivo W.
    NEURO-ONCOLOGY PRACTICE, 2020, 7 (06) : 583 - 588
  • [38] Optimizing Neuro-Oncology Imaging: A Review of Deep Learning Approaches for Glioma Imaging
    Shaver, Madeleine M.
    Kohanteb, Paul A.
    Chiou, Catherine
    Bardis, Michelle D.
    Chantaduly, Chanon
    Bota, Daniela
    Filippi, Christopher G.
    Weinberg, Brent
    Grinband, Jack
    Chow, Daniel S.
    Chang, Peter D.
    CANCERS, 2019, 11 (06)
  • [39] Vaccination strategies for neuro-oncology
    Sampson, John H.
    Mitchell, Duane A.
    NEURO-ONCOLOGY, 2015, 17 : 15 - 25
  • [40] Imaging Criteria in Neuro-oncology
    Nowosielski, Martha
    Wen, Patrick Y.
    SEMINARS IN NEUROLOGY, 2018, 38 (01) : 24 - 31
12345